Read the latest positive news, breakthroughs, and inspiring stories about lymphoma, curated daily by BrightWire.
A 14-year-old boy from Wales is cancer-free again after a relapse sent him to a groundbreaking clinical trial with 50-50 odds. His secret to staying calm? Advice from his dad, who also survived lymphoma.
A woman who beat lymphoma finally embraced the firefighter whose bone marrow donation gave her a second chance. Their emotional Chicago reunion shows how one simple registry signup can change everything.
Sutter Health enrolled its first patient in a groundbreaking cancer trial that could stop lymphoma from returning before it's even visible on scans. The treatment brings cutting-edge cellular therapy to the East Bay, eliminating the need for patients to travel to distant medical centers.
Scientists at MD Anderson Cancer Center are testing a breakthrough cell therapy that could finally bring hope to patients with hard-to-treat T-cell lymphoma. The new approach overcomes a major obstacle that previously made this personalized cancer treatment impossible for these patients.
A lymphoma survivor in Qatar is sharing his cancer journey to give hope to others facing similar battles. Mohamed Othman's story of faith and determination shows that recovery is possible even through the toughest challenges.
Ben Whitehead entered remission from a one-of-a-kind lymphoma after targeted therapy starved his cancer cells. The Mount Gambier father went from three months to live to planning his future in just eight months.
Doctors are finally cracking the code on rare T-cell lymphomas that have resisted treatment for decades. A team of researchers across eight major U.S. medical centers is mapping personalized treatments that could transform survival rates.
A breakthrough "off-the-shelf" CAR-T therapy eliminated residual cancer cells three times more effectively than standard care in lymphoma patients. The treatment could prevent cancer recurrence in high-risk patients for the first time.
A groundbreaking clinical trial has just given Japanese patients with an aggressive form of lymphoma a powerful new treatment option. The SUNMO trial results convinced Japan's health ministry to approve the therapy as a new standard of care.
More than 250 lymphoma survivors will learn stress management and coping techniques through a groundbreaking national trial. The free virtual program treats resilience as a teachable skill, not something you're born with.